Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Potential source : Jaguarhealth.gcs-web.com save search
Napo Pharmaceuticals Surveys of Neurologists, Patients, and Caregivers Regarding Amyotrophic Lateral Sclerosis (ALS) Treatment Indicate Real World Burden of Diarrhea and Potential Treatment Interruption
Published: 2023-08-16 (Crawled : 12:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M
|
Health Technology
|
| O: 6.57%
H: 0.0%
C: 0.0%
diarrhea indicate world sclerosis treatment pharmaceuticals potential
Jaguar Health Announces Upsizing of At-the-Market (ATM) Financing Program by $15.3 Million with Ladenburg Thalmann & Co. Inc. for Potential Future Financing Needs
Published: 2021-04-15 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M
|
Health Technology
|
| O: -2.6%
H: 1.46%
C: -14.34%
potential
Jaguar Health Signs Definitive Agreement for $5 Million Non-dilutive Financing Transaction Involving Sale of Royalty Rights Related to Future Potential Crofelemer (Mytesi) COVID-related Indication Revenue Stream
Published: 2021-03-09 (Crawled : 13:33) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M
|
Health Technology
|
| O: 7.37%
H: 1.29%
C: -6.44%
covid potential crofelemer
Jaguar Health Enters Binding Term Sheet for $5 Million Non-dilutive Financing Transaction Involving Sale of Royalty Rights Related to Future Potential Crofelemer (Mytesi) COVID-related Indication Revenue Stream
Published: 2021-03-05 (Crawled : 14:11) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M
|
Health Technology
|
| O: 1.86%
H: 4.88%
C: -2.44%
covid potential crofelemer
REMINDER: Jaguar Health and Sponsor of Proposed Post Pandemic Recovery Equity SPAC to Host Webcast Wednesday, January 27th at 8:30 AM Eastern Time to Provide Updates Regarding the Potential Merger of Napo EU, the Company’s Anticipated Subsidiary in Italy
Published: 2021-01-26 (Crawled : 14:08) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M
|
Health Technology
|
| O: 1.2%
H: 0.0%
C: -3.26%
spac merge potential
Jaguar Health and Sponsor of Proposed Post Pandemic Recovery Equity SPAC to Host Webcast Wednesday, January 27th at 8:30 AM Eastern Time to Provide Updates Regarding the Potential Merger of Napo EU, the Company’s Anticipated Subsidiary in Italy
Published: 2021-01-21 (Crawled : 14:08) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M
|
Health Technology
|
| O: 16.1%
H: 0.59%
C: -8.26%
spac merge potential
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.